Effect observation of dagliazine in treatment of patients with heart failure with reduced ejection fraction

LIU Rongzhi; LIN Zixiang; CHEN Haijin; QIU Xiaoyan; HE Jianjun; WAN Yu; WEN Shengxin; CHEN Shaoyuan

doi:10.7619/jcmp.20223187

Journal of Clinical Medicine in Practice > 2023 > 27(3): 35-39, 45. > DOI: 10.7619/jcmp.20223187

LIU Rongzhi, LIN Zixiang, CHEN Haijin, QIU Xiaoyan, HE Jianjun, WAN Yu, WEN Shengxin, CHEN Shaoyuan. Effect observation of dagliazine in treatment of patients with heart failure with reduced ejection fraction[J]. Journal of Clinical Medicine in Practice, 2023, 27(3): 35-39, 45. DOI: 10.7619/jcmp.20223187

Citation:

PDF (1447 KB)

Effect observation of dagliazine in treatment of patients with heart failure with reduced ejection fraction

Internal Department of Cardiovascular Medicine, Union Shenzhen Hospital of Huazhong University of Science and Technology, Shenzhen, Guangdong, 518000

More Information

Received Date: October 25, 2022
Available Online: March 01, 2023

Graphical Abstract

Abstract

Abstract

Objective
To investigate the effect of dagliazine on the levels of CXC chemokine ligand 16 (CXCL16), stromal cell-derived factor-1 (SDF-1) and cyclophilin A (CypA) in patients with heart failure with reduced ejection fraction (HFrEF).
Methods
A total of 156 HFrEF patients were divided into intervention group and control group according to different intervention plans, with 78 cases in each group. The control group was treated with conventional standardized drug intervention therapy, while the intervention group was treated with dagliazine on the basis of the control group. The total effective rate was compared between the two groups; the changes of CXCL16, SDF-1 and CypA levels before and after treatment were compared between the two groups; the Spearman correlation coefficient was used to analyze the correlations of CXCL16, SDF-1 and CypA with clinical efficacy; the levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP), high-sensitivity C reactive protein (hs-CRP), cardiac troponin I (cTnI) and tumor necrosis factor-α (TNF-α) before and after treatment were compared between the two groups; the changes of ventricular remodeling indexes [left ventricular end-diastolic diameter (LVEDd), left ventricular end-systolic diameter (LVESd), left ventricular ejection fraction (LVEF)]before and after treatment were compared between the two groups; the Pearson correlation coefficient was used to analyze the correlations of CXCL16, SDF-1 and CypA with ventricular remodeling indexes.
Results
The total effective rate of the intervention group was 89.74%, which was significantly higher than 73.08% of the control group (P < 0.05). After treatment, the levels of CXCL16 and CypA in both groups were significantly lower than those before treatment, while the SDF-1 level was significantly higher than that before treatment, and the levels of CXCL16 and CypA in the intervention group were significantly lower than those in the control group, while the SDF-1 level was significantly higher than that in the control group (P < 0.05). Spearman correlation coefficient analysis showed that CXCL16 and CypA levels were significantly positively correlated with clinical efficacy (P < 0.05), while SDF-1 level was significantly negatively correlated with clinical efficacy (P < 0.05). After treatment, the levels of NT-proBNP, hs-CRP, cTnI and TNF-α in both groups decreased significantly, and the levels of these indexes in the intervention group were significantly lower than those in the control group (P < 0.05). After treatment, the LVEDd and LVESd in both groups were significantly lower than those before treatment, while the LVEF was significantly higher than that before treatment, and the LVEDd in the intervention group was significantly lower than that in the control group, while the LVEF was significantly higher than that in the control group (P < 0.05). Pearson correlation coefficient analysis showed that CXCL16, SDF-1 and CypA were significantly correlated with LVEF and LVEDd (P < 0.05).
Conclusion
Dagliazine is effective in the treatment of patients with HFrEF, which can increase the levels of CXCL16, SDF-1, CypA and cardiac remodeling indexes, and improve the patient's quality of life.

FullText(HTML)

References (20)

References

[1]	KURIYAMA S. A potential mechanism of cardio-renal protection with sodium-glucose cotransporter 2 inhibitors: amelioration of renal congestion[J]. Kidney Blood Press Res, 2019, 44(4): 449-456. doi: 10.1159/000501081
[2]	MUTHIAH, VADUGANATHAN, MD, et al. Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials[J]. Lancet, 2020, 396(10244): 121-128. doi: 10.1016/S0140-6736(20)30748-0
[3]	KLUGER A Y, TECSON K M, LEE A Y, et al. Class effects of SGLT2 inhibitors on cardiorenal outcomes[J]. Cardiovasc Diabetol, 2019, 18(1): 99. doi: 10.1186/s12933-019-0903-4
[4]	HABIB M. Dapagliflozin in patients with heart failure and reduced ejection fraction[J]. N Engl J Med, 2020, 382(10): 972-973. doi: 10.1056/NEJMc1917241
[5]	WIVIOTT S D, RAZ I, BONACA M P, et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes[J]. N Engl J Med, 2019, 380(4): 347-357. doi: 10.1056/NEJMoa1812389
[6]	翟春丽, 许涵. 血清CREG及CXCL16水平与急性心肌梗死后认知功能障碍的关系[J]. 内科急危重症杂志, 2018, 24(6): 478-479. https://www.cnki.com.cn/Article/CJFDTOTAL-NKJW201806015.htm
[7]	王琳琳, 李文建, 李易明, 等. 超声联合SDF-1微泡对糖尿病性心肌病大鼠心肌损伤的保护作用[J]. 现代中西医结合杂志, 2018, 27(14): 1501-1504. doi: 10.3969/j.issn.1008-8849.2018.14.006
[8]	中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(10): 760-789. doi: 10.3760/cma.j.issn.0253-3758.2018.10.004
[9]	徐建辉, 李睿, 李朋, 等. 射血分数降低的急性心力衰竭患者远期预后观察[J]. 内科急危重症杂志, 2018, 24(5): 410-412. https://www.cnki.com.cn/Article/CJFDTOTAL-NKJW201805020.htm
[10]	郭彩红, 高秀莹. 达格列净对2型糖尿病伴代谢综合征患者代谢指标影响[J]. 临床军医杂志, 2018, 46(5): 585-587. https://www.cnki.com.cn/Article/CJFDTOTAL-JYGZ201805022.htm
[11]	徐楠, 李慕子, 张丽, 等. HFrEF患者超声右心功能评价指标与NT-proBNP的相关性研究[J]. 中国分子心脏病学杂志, 2019, 19(4): 2984-2987. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGFB201904009.htm
[12]	尚少红, 张红, 李湘. 血清Cystatin C、MMP-2及hs-CRP/PAB对急性心肌梗死患者PCI术后并发心衰的预测价值[J]. 河北医药, 2019, 41(3): 343-346, 351. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYZ201903005.htm
[13]	宋增新. hs-CRP和BNP检测对慢性阻塞性肺疾病急性加重期合并心力衰竭病人的临床意义[J]. 中西医结合心脑血管病杂志, 2018, 16(12): 1704-1706. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY201812020.htm
[14]	陈姣, 周杰, 汤冰倩, 等. 达格列净治疗糖尿病合并心衰的疗效及其血管内皮功能和炎症因子的影响[J]. 心血管康复医学杂志, 2020, 29(5): 599-603. https://www.cnki.com.cn/Article/CJFDTOTAL-XXGK202005018.htm
[15]	杨攀, 张琼, 王学影. 达格列净治疗射血分数降低心衰患者的疗效观察[J]. 广西医科大学学报, 2021, 38(7): 1436-1441. https://www.cnki.com.cn/Article/CJFDTOTAL-GXYD202107030.htm
[16]	徐敏, 张华, 谢永魁. CT联合血清PDGF CXCL16用于冠心病冠脉斑块稳定性诊断的临床价值[J]. 浙江临床医学, 2018, 20(10): 1654-1656. https://www.cnki.com.cn/Article/CJFDTOTAL-JYYL202203011.htm
[17]	陈滔, 郑鑫, 黄杨, 等. 富血小板血浆通过调节SDF-1/CXCR4信号通路影响糖尿病皮瓣新生血管化机制的研究[J]. 中华全科医学, 2016, 14(6): 953-956. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201606023.htm
[18]	马懿, 吴铮铮, 潘先花, 等. 白藜芦醇苷通过上调SIRT3和SDF-1延缓大鼠心肌纤维化[J]. 细胞与分子免疫学杂志, 2018, 34(9): 776-781. https://www.cnki.com.cn/Article/CJFDTOTAL-XBFM201809003.htm
[19]	汤玮, 胡荣, 赵冬婧, 等. 血清CyPA、MMP-9水平对急性心肌梗死PCI后近期缺血性并发症的预测分析[J]. 中国循证心血管医学杂志, 2022, 14(3): 317-320, 325. https://www.cnki.com.cn/Article/CJFDTOTAL-PZXX202203015.htm
[20]	ZOU C Y, LIU X K, SANG Y Q, et al. Effects of SGLT2 inhibitors on cardiovascular outcomes and mortality in type 2 diabetes: a meta-analysis[J]. Medicine, 2019, 98(49): e18245.

[1]	YAN Shanshan, WANG Ya, YAO Dongfang. Development of a risk prediction model for dialysis disequilibrium syndrome in hemodialysis patients based on decision tree algorithm[J]. Journal of Clinical Medicine in Practice, 2024, 28(18): 51-55, 61. DOI: 10.7619/jcmp.20242224
[2]	CHEN Xiaohui, JIAO Zishan, WANG Nana, SHA Kaihui. Decision tree C5.0 versus Logistic regression model in predicting postpartum diastasis recti abdominis[J]. Journal of Clinical Medicine in Practice, 2023, 27(16): 115-120, 126. DOI: 10.7619/jcmp.20230893
[3]	LU Xiangyue, WANG Yannian, LI Quanzhong. Analysis in performance of GM(1, 1) model in predicting blood glucose at different ranges[J]. Journal of Clinical Medicine in Practice, 2021, 25(9): 23-28, 36. DOI: 10.7619/jcmp.20210757
[4]	WANG Ni, CHEN Yaping, CAO Yundan, TANG Weifen, XIA Qianying. Application of optimized distribution and subarea administration in the transfusion department of out-patient and emergency[J]. Journal of Clinical Medicine in Practice, 2019, 23(18): 125-128. DOI: 10.7619/jcmp.201918036
[5]	ZHANG Ming, YU Fangfang, ZHANG Xiaoxia, CAO Rong, CHU Jianghui. Optimized nursing strategy for thoracic closed drainage and its clinical outcomes[J]. Journal of Clinical Medicine in Practice, 2017, (16): 50-52. DOI: 10.7619/jcmp.201716016
[6]	LI Ying, WANG Rongfang. Clinical efficacy of optimized emergency nursing in rescue of patients with acute myocardial infarction[J]. Journal of Clinical Medicine in Practice, 2017, (4): 8-10. DOI: 10.7619/jcmp.201704003
[7]	LI Yi, LI Haoyue. The influence of optimized emergency nursing procedure on the rescue efficiency of emergency patients[J]. Journal of Clinical Medicine in Practice, 2015, (22): 38-40. DOI: 10.7619/jcmp.201522013
[8]	WANG Man, LI Rong, GU Limei, ZHAO Lingyan, LI Fengxin, GU Moli. Application of optimized nursing procedure in emergency rescue of acute myocardial infarction patients[J]. Journal of Clinical Medicine in Practice, 2015, (8): 9-11,24. DOI: 10.7619/jcmp.201508003
[9]	WANG Jie, XIANG Shuangrong, YANG Hua. Research on effect of optimized nursing model in improving sleep quality and emotional state of patients with congestive heart failure[J]. Journal of Clinical Medicine in Practice, 2014, (10): 10-12. DOI: 10.7619/jcmp.201410004
[10]	CHENG Yan, JI Dan, CHEN Lili. Effect observation of optimized oral nursing on the treatment of children with herpetic stomatitis[J]. Journal of Clinical Medicine in Practice, 2013, (8): 120-121. DOI: 10.7619/jcmp.201308045

Cited By

Cited by

Periodical cited type(2)

1.	张存莉, 张瑛, 吴进, 刘昌奎. 全身奥硝唑给药及局部盐酸米诺环素给药用于牙种植术后的临床效果. 临床医学研究与实践. 2019(13): 18-19 .
2.	叶波阳, 汤自明, 廖仕芬. 牙龈与牙槽嵴修整手术对牙齿修复的影响分析. 中国当代医药. 2018(17): 116-118 .

Other cited types(1)

Get Citation

PDF

XML

Article views (343) PDF downloads (16) Cited by(3)

Turn off MathJax

Article Contents

Abstract

References

Effect observation of dagliazine in treatment of patients with heart failure with reduced ejection fraction